CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Snodgres Jon Chief Financial Officer | Option exercise | +1,214 | $59.52 | $72K | 39,899 |
| 2022-03-08 | Snodgres Jon Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +2,952 | 13,707 | ||
| 2022-03-08 | Snodgres Jon Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | +1,214 | 2,574 | ||
| 2022-03-01 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −7,292 | $194.06 | $1.4M | 199,315 |
| 2022-03-01 | RYAN THOMAS F JR Director | Option exercise | +1,000 | $38.76 | $39K | 3,457 |
| 2022-03-01 | RYAN THOMAS F JR Director | Sale | −1,000 | $198.48 | $198K | 2,457 |
| 2022-03-01 | RYAN THOMAS F JR Director | Sale | −1,000 | $197.58 | $198K | 1,457 |
| 2022-03-01 | RYAN THOMAS F JR Director | Option exercise · Stock Option (Right to Buy) | +1,000 | 0 | ||
| 2022-02-28 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −473 | $196.70 | $93K | 18,172 |
| 2022-02-28 | KURIYEL RALF Senior VP, R&D | Grant or award | +4,234 | 22,406 | ||
| 2022-02-28 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −1,584 | $196.70 | $312K | 20,822 |
| 2022-02-28 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −661 | $196.70 | $130K | 32,279 |
| 2022-02-28 | Snodgres Jon Chief Financial Officer | Grant or award | +5,922 | 38,201 | ||
| 2022-02-28 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −2,468 | $196.70 | $485K | 35,733 |
| 2022-02-28 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −3,170 | $196.70 | $624K | 189,901 |
| 2022-02-28 | Hunt Anthony Chief Executive Officer | Grant or award | +30,074 | 219,975 | ||
| 2022-02-28 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −13,368 | $196.70 | $2.6M | 206,607 |
| 2022-02-28 | Gebski Christine See Remarks | Shares withheld for taxes | −598 | $196.70 | $118K | 34,427 |
| 2022-02-27 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −477 | $196.70 | $94K | 18,645 |
| 2022-02-27 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −695 | $196.70 | $137K | 32,940 |
Page 21 of 23 · 455 trades